Schweighardt B - Search Results

1

Changes in CD4+ T-cell differentiation phenotype during structured treatment interruption in patients with chronic HIV-1 infection.

Alexander TH, Ortiz GM, Wellons MF, Allen A, Grace EJ 2nd, Schweighardt B, Brancato J, Sandberg JK, Furlan SN, Miralles GD, Nixon DF, Bartlett JA. Alexander TH, et al. Among authors: schweighardt b. J Acquir Immune Defic Syndr. 2003 Dec 15;34(5):475-81. doi: 10.1097/00126334-200312150-00005. J Acquir Immune Defic Syndr. 2003. PMID: 14657757

2

Emergence of drug-resistant HIV-1 variants in patients undergoing structured treatment interruptions.

Schweighardt B, Ortiz GM, Grant RM, Wellons M, Miralles GD, Kostrikis LG, Bartlett JA, Nixon DF. Schweighardt B, et al. AIDS. 2002 Nov 22;16(17):2342-4. doi: 10.1097/00002030-200211220-00018. AIDS. 2002. PMID: 12441810

3

Immune escape mutations detected within HIV-1 epitopes associated with viral control during treatment interruption.

Schweighardt B, Wrin T, Meiklejohn DA, Spotts G, Petropoulos CJ, Nixon DF, Hecht FM. Schweighardt B, et al. J Acquir Immune Defic Syndr. 2010 Jan;53(1):36-46. doi: 10.1097/QAI.0b013e3181c4b885. J Acquir Immune Defic Syndr. 2010. PMID: 19910798 Free PMC article.

4

R5 human immunodeficiency virus type 1 (HIV-1) replicates more efficiently in primary CD4+ T-cell cultures than X4 HIV-1.

Schweighardt B, Roy AM, Meiklejohn DA, Grace EJ 2nd, Moretto WJ, Heymann JJ, Nixon DF. Schweighardt B, et al. J Virol. 2004 Sep;78(17):9164-73. doi: 10.1128/JVI.78.17.9164-9173.2004. J Virol. 2004. PMID: 15308712 Free PMC article.

5

ELISPOT cell rescue.

Meiklejohn DA, Karlsson RK, Karlsson AC, Chapman JM, Nixon DF, Schweighardt B. Meiklejohn DA, et al. Among authors: schweighardt b. J Immunol Methods. 2004 May;288(1-2):135-47. doi: 10.1016/j.jim.2004.03.006. J Immunol Methods. 2004. PMID: 15183092

6

Enhanced replication of R5 HIV-1 over X4 HIV-1 in CD4(+)CCR5(+)CXCR4(+) T cells.

Roy AM, Schweighardt B, Eckstein LA, Goldsmith MA, McCune JM. Roy AM, et al. Among authors: schweighardt b. J Acquir Immune Defic Syndr. 2005 Nov 1;40(3):267-75. doi: 10.1097/01.qai.0000176593.14172.52. J Acquir Immune Defic Syndr. 2005. PMID: 16249699

7

Development of an HIV-1 reference panel of subtype B envelope clones isolated from the plasma of recently infected individuals.

Schweighardt B, Liu Y, Huang W, Chappey C, Lie YS, Petropoulos CJ, Wrin T. Schweighardt B, et al. J Acquir Immune Defic Syndr. 2007 Sep 1;46(1):1-11. doi: 10.1097/QAI.0b013e318074eb5a. J Acquir Immune Defic Syndr. 2007. PMID: 17514017

8

Prevalence of cross-reactive HIV-1-neutralizing activity in HIV-1-infected patients with rapid or slow disease progression.

van Gils MJ, Euler Z, Schweighardt B, Wrin T, Schuitemaker H. van Gils MJ, et al. Among authors: schweighardt b. AIDS. 2009 Nov 27;23(18):2405-14. doi: 10.1097/QAD.0b013e32833243e7. AIDS. 2009. PMID: 19770692

9

Cross-reactive neutralizing humoral immunity does not protect from HIV type 1 disease progression.

Euler Z, van Gils MJ, Bunnik EM, Phung P, Schweighardt B, Wrin T, Schuitemaker H. Euler Z, et al. Among authors: schweighardt b. J Infect Dis. 2010 Apr 1;201(7):1045-53. doi: 10.1086/651144. J Infect Dis. 2010. PMID: 20170371

10

Loss of HIV-1-specific T-cell responses associated with very rapid HIV-1 disease progression.

Streeck H, Schweighardt B, Jessen H, Allgaier RL, Wrin T, Stawiski EW, Jessen AB, Allen TM, Walker BD, Altfeld M. Streeck H, et al. Among authors: schweighardt b. AIDS. 2007 Apr 23;21(7):889-91. doi: 10.1097/QAD.0b013e3280f77439. AIDS. 2007. PMID: 17415054 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters